Skip to main content
. Author manuscript; available in PMC: 2015 Jul 1.
Published in final edited form as: Pain. 2014 Apr 13;155(7):1328–1338. doi: 10.1016/j.pain.2014.04.009

Fig. 1. Tryptase and carboxypeptidase A are increased in CP/CPPS patients.

Fig. 1

(A) Mast cell tryptase was significantly increased in EPS from CP/CPPS (n=16) patients compared to healthy volunteers (n=6). (B) Urine samples (V3 and V2) collected from CP/CPPS (n=29) patients showed increased presence of carboxypeptidase A (CPA3) compared to control (n=12); (C) however, NGF levels did not change compared to control group. (D) Western blots were performed with 20µg/sample of mouse prostate from NOD mice (n=4) with EAP. (E) Densitometry analysis of immunoblot demonstrated higher molecular weight forms of mMCP-6 in the prostate of EAP-NOD mice compared to naive. Data represent the mean ± SEM. (*) denotes p<0.05, ** p<0.01 and ***p<0.001 compared with control.